The experimental study of the local irritating action of N-acetylglucosamine and quercetin in intramuscular administration

Authors

DOI:

https://doi.org/10.24959/cphj.18.1475

Keywords:

N-acetylglucosamine, quercetin, intramuscular administration, local irritating action

Abstract

The current problem of the modern medical and pharmaceutical industry is the insufficient number of effective and safe drugs with the polytropic action for the treatment of ischemic and inflammatory-destructive diseases of various organs. In this regard, pharmaceutical combinations, which are based on derivatives of glucosamine and quercetin in parenteral dosage forms, are of scientific interest.

Aim. To study experimentally the local irritating action of N-acetylglucosamine, quercetin and their combination in intramuscular administration.

Materials and methods. The study was carried out using 40 intact rats. To assess the local irritating action of the drugs studied the histomorphological study of the state of the rat muscle tissue at the site of administration was carried out using standard methods of bright field microscopy.

Results. In the course of the study it was shown that after a 10-day administration of the solution of N-acetylglucosamine and its combination with quercetin in the muscle tissue of rats there were no significant changes, which would indicate the local irritating action of these drugs. At the same time, the solution of quercetin had a moderate local irritating effect with a pronounced reversible nature. The results obtained indicate a high level of safety and wide possibilities of using the drugs studied in clinical practice in the intramuscular route of administration.

Conclusions. N-acetylglucosamine, quercetin and their combination under the conditions of intramuscular injection do not have a significant local irritating effect, which makes it advisable to introduce these drugs in dosage forms for injection.

Author Biographies

S. K. Shebeko, National University of Pharmacy

Candidate of Pharmacy (Ph.D.), associate professor of the Clinical Pharmacology and Clinical Pharmacy Department

A. S Shalamay, PJSC SIC “Borshchahivskiy CPP”*

Candidate of Chemistry (Ph.D.), deputy director of research

O. O. Liapunova, National University of Pharmacy

Candidate of Pharmacy (PhD), associate professor of the Industrial Pharmacy Department

References

Shebeko, S. K., Zupanets, I. A., Popov, O. S., Tarasenko, O. O., & Shalamay, A. S. (2018). Effects of Quercetin and Its Combinations on Health. Polyphenols: Mechanisms of Action in Human Health and Disease, 373–394. https://doi.org/10.1016/b978-0-12-813006-3.00027-1

Tuliakov, V. O., Zupanets, K. O., Shebeko, S. K. (2009). Pharmacology and Drug Toxicology, 3 (10), 3–8.

Parasuraman, S., Anand David, A., & Arulmoli, R. (2016). Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacognosy Reviews, 10(20), 84–89. https://doi.org/10.4103/0973-7847.194044

Kovalenko, V. N. (2017)’. Kompendium 2017 – lekarstvennye preparaty. – Kyiv: Morion, 2560.

Shebeko, S. K., Zupanets, I. A., Shalamai, A. S. (2017). Pharmacology and Drug Toxicology, 6, 66–71.

Shebeko, S. K., Zupanets, I. A., Propisnova, V. V., & Shalamay, A. S. (2018). Ukraïns’kij bìofarmacevtičnij žurnal, 2, 56–60. https://doi.org/10.24959/ubphj.18.170

Shebeko, S. K., Zupanets, I. A., & Shalamay, A. S. (2018). Ukraïns’kij bìofarmacevtičnij žurnal, 1(54), 25–30. https://doi.org/10.24959/ubphj.18.155

Guide for the care and use of laboratory animals, 8th edition. (2011). Washington: The National Academies Press, 246.

European convention for the protection of vertebrate animals used for experimental and other scientific purpose: Council of Europe (1986). Strasbourg, 52.

Kovalenko, V. M., Tsypkun, A. H. (2007). Doklinichne vyvchennia mistsevopodrazniuvalnoi dii likarskykh zasobiv. Kyiv, 54.

Sarkisov, D. S., Perov, Yu. L. (1996). Mikroskopicheskaia tekhnika. Moscow: Meditsina, 544.

Truhacheva, N. V. (2012). Matematicheskaia statistika v mediko–biologicheskih issledovaniiah s primeneniem paketa Statistica. Moscow: GEOTAR–Media, 379.

Downloads

Published

2018-11-29

Issue

Vol. 22 No. 4 (2018)

Section

Pre-clinical studies of new drugs

License

Copyright (c) 2018 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).